^
    2ms
    Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=12, Terminated, Eisai Inc. | Completed --> Terminated; Strategic decision, which is unrelated to safety
    Trial termination
    |
    temozolomide • E7016